摘要
在动植物基因组中广泛存在一类非编码蛋白的小RNA,即microRNA(miRNA)。miRNA在肿瘤的形成和转录后调节基因表达中起重要作用。miR-15a和miR-16-1表达水平的改变与慢性淋巴细胞白血病(CLL)有关,原癌基因bcl-2可能是miR-15a和miR-16-1的靶基因;活化B细胞型弥漫性大B细胞淋巴瘤(DLBCL)、儿童Burkitt淋巴瘤等肿瘤细胞miR-155的拷贝数明显增高,认为miR-155表达水平可以作为DLBCL诊断和预后的重要指标;miR-17-92簇(miR-15a,miR-16-1,miR-155,miR-17-92cluster,miR-142)是一组可能的肿瘤相关基因。
Plant and animal genomes contain an abundance of small genes, known as microRNAs ( miRNAs), which play an important role in the pathogenesis of tumors and negatively regulate the expression of protein-encoding genes at the post-transcriptional level. The miR-15a-miR-16-1 cluster is frequently deleted and/or downregulated in the majority of CLL cases, miR-15 and miR-16 induce apoptosis by targeting BCL2. High expression of precursor miR-155 was detected in activated B cell phenotype diffuse large B cell lymphoma (DLBCL) and Burkitt' s lymphoma (BL). The miR-155 level may be useful diagnostically and prognostically in DLBCL. The miR-17-92 cluster (miR-15a, miR-16-1, miR-155,miR-17-92 cluster, miR-142) acts as an oncogene under one set of conditions and as a tumor suppressor under another.
出处
《国际病理科学与临床杂志》
CAS
2007年第1期1-5,共5页
Journal of International Pathology and Clinical Medicine
基金
江苏省135工程医学重点人才基金(RC2002044)~~